C1 Esterase Inhibitor (Human) | CoronaCentral

C1 Esterase Inhibitor (Human) [Drug]

Wikidata: Q22075742

Published and Preprint Papers

Topics & Article Type(s)

Title

Clinical Trials, Therapeutics [Research]

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.

Vaccines [Research]

Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA).

Molecular Biology [Research]

Targeted Blood Plasma Proteomics and Hemostasis Assessment of Post COVID-19 Patients with Acute Myocardial Infarction.

Clinical Reports [Research]

COVID-19 infection and vaccination in patients with hereditary angioedema: a multicentric study.

Psychology [Research]

Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being.

Therapeutics [Review]

Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression.

Risk Factors [Research]

COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.

Molecular Biology [Research]

Molecular Basis for Bordetella pertussis Interference with Complement, Coagulation, Fibrinolytic, and Contact Activation Systems: the Cryo-EM Structure of the Vag8-C1 Inhibitor Complex.

Clinical Reports [Research]

Patients With Hereditary Angioedema Do Not Develop More Severe COVID-19 but SARS-CoV-2 Infection May Trigger Attacks: 66 Cases

Clinical Reports, Risk Factors [Research]

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.